Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial

Title:	Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial
Authors:	Modi, Shanu^{Aff1, IDs41591025039814_cor1}; Jacot, William^Aff2; Iwata, Hiroji^Aff3; Park, Yeon Hee^Aff4; Vidal Losada, Maria^Aff5; Li, Wei^Aff6; Tsurutani, Junji^Aff7; Ueno, Naoto T.^Aff8; Zaman, Khalil^Aff9; Prat, Aleix^Aff10; Papazisis, Konstantinos^Aff11; Rugo, Hope S.^Aff12; Yamashita, Toshinari^Aff13; Harbeck, Nadia^Aff14; Im, Seock-Ah^Aff15; De Laurentiis, Michelino^Aff16; Pierga, Jean-Yves^Aff17; Wang, Xiaojia^Aff18; Gombos, Andrea^Aff19; Tokunaga, Eriko^Aff20; Orbegoso Aguilar, Cecilia^Aff21; Yung, Lotus^Aff22; Xiao, Feng^Aff23; Cheng, Yingkai^Aff24; Cameron, David^Aff25
Source:	Nature Medicine. 31(12):4205-4213
Database:	Springer Nature Journals